We are pleased to announce that Lieff Cabraser partner Michael Levin-Gesundheit has been named to the California Daily Journal’s “Top 40 Under 40” list for 2024, recognizing him as one of California’s best lawyers under 40. The Journal highlights Michael’s leadership in the prescription opioids litigation, particularly his role on the San Francisco opioid bellwether team, where he helped secure a $229.6 million settlement with Walgreens for failing to ensure prescription due diligence. His work has been instrumental in driving multi-billion-dollar national settlements with other major pharmacies, including CVS and Walmart.
Congratulations to Michael on this prestigious and well-deserved recognition!
About Michael Levin-Gesundheit
A partner in Lieff Cabraser’s San Francisco office, Michael Levin-Gesundheit is dedicated to seeking fairness for government entities, employees, consumers, and injury victims, regardless of the resources of the defendant. Michael served on the San Francisco opioid bellwether team, working to obtain evidence and on the 2022 trial, where he developed multiple trial witnesses. His focus, in San Francisco and across other opioid cases in the multidistrict litigation, was Walgreens, for its role in preventing and discouraging its pharmacists from conducting the prescription due diligence required under the Controlled Substances Act. Walgreens ultimately settled with San Francisco for $229.6 million to avoid a second-phase abatement trial.
Other corporations Michael has taken on include Goldman Sachs and Microsoft for gender discrimination, Google for invasions of privacy, a major pharmaceutical company for fraudulent marketing practices, and an international consultancy for mistreatment of H-1B visa workers.
Contact us
Use the form below to contact a lawyer at Lieff Cabraser.
